Doxophylline

# Doxophylline ## Overview - **Classification**: Xanthine derivative; Bronchodilator. - **Mechanism**: Inhibits phosphodiesterase (PDE) enzymes, specifically PDE3 and PDE4. This increases intracellular cAMP, leading to smooth muscle relaxation and bronchodilation. It also exerts antitussive and anti-inflammatory properties with fewer side effects than theophylline. ## Primary Indications 1. **Bronchial Asthma** - Chronic treatment and symptom control. 2. **Chronic Obstructive Pulmonary Disease (COPD)** - Symptom management in stable disease. ## Adult Dosing ### Standard Dosing **Bronchial Asthma and COPD** - **Dose**: **400 mg** - **200 mg** depending on severity and formulation. - **Frequency**: Twice or three times daily (BID or TID). - **Route**: Oral (Tablet or Syrup). - **Maximum Daily Dose**: **1200 mg**. ### Specific Regimen (Immediate Release) - **Initiation**: **200 mg** TID (every 8 hours). - **Maintenance**: **400 mg** BID or TID, adjusted according to response. ### Dose Adjustments - **Renal Impairment**: No specific dose reduction generally needed. Use with caution. - **Hepatic Impairment**: Significant reduction required due to reduced clearance. Start with **half the usual dose**. Closely monitor for signs of toxicity. - **Elderly Patients**: Use lower initial doses (**200 mg** BID) due to potentially altered clearance and increased sensitivity. ## Pediatric Dosing Doxophylline use in pediatrics is off-label or based on limited regional guidelines. Consult local pediatric protocols. ### Neonates (0-28 days) - **Safety**: **Contraindicated**. Lack of specific safety and efficacy data. ### Infants (1-12 months) - **Safety**: **Contraindicated**. Use highly discouraged. ### Children (1-12 years) - **Primary Indication**: Asthma. - **Dose**: **6-9 mg/kg/day** (Split into 2 or 3 doses). - **Frequency**: BID or TID. - **Maximum**: **400 mg/day** (or the lowest effective adult dose). - **Special Notes**: Syrup formulation often preferred for ease of dosing. Closely monitor for CNS side effects. ### Adolescents (13-18 years) - **Approach**: Transition to low-end adult dosing. - **Dose**: Start with **200 mg** BID or TID. - **Maximum**: **1200 mg/day**. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to xanthine derivatives (theophylline, caffeine). - **Absolute**: Acute myocardial infarction. - **Absolute**: Severe hypotension. - **Absolute**: Porphyria. ### Common Adverse Effects - **Very Common (>10%)**: Nausea, vomiting, headache. - **Common (1-10%)**: Palpitations, dizziness, dyspepsia, insomnia, restlessness. - **Serious but Rare**: Seizures, life-threatening arrhythmias (ventricular fibrillation). ### Key Drug Interactions - **Erythromycin/Macrolides**: Significantly **increases** doxophylline plasma levels, raising toxicity risk. Requires dose reduction. - **Cimetidine**: Inhibits doxophylline metabolism, increasing serum concentration. Monitor closely. - **Phenobarbital/Phenytoin**: Induce metabolism, potentially **decreasing** doxophylline effectiveness. Monitor clinical response. - **Allopurinol (High Dose)**: May increase doxophylline concentration; monitor for toxicity. ## Monitoring & Follow-up - **Before Treatment**: Baseline cardiovascular assessment (ECG if risk factors present). - **During Treatment**: Monitor for signs of toxicity (nausea, restlessness, arrhythmias). - **Therapeutic Drug Monitoring (TDM)**: Unlike theophylline, TDM is not routinely required, but may be helpful in cases of suspected toxicity or poor response. - **Clinical Signs**: Assess respiratory rate, heart rate, and symptom control. ## Clinical Pearls - 💡 **Tip 1**: Doxophylline is generally better tolerated than theophylline due to its lower binding affinity to adenosine receptors. - 💡 **Tip 2**: Advise patients to take the drug with food to minimize gastrointestinal discomfort. - 💡 **Tip 3**: If a dose is missed, take it as soon as remembered, unless it’s almost time for the next dose; never double the dose. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.